Literature DB >> 21382335

Malaria in the Greater Mekong Subregion: heterogeneity and complexity.

Liwang Cui1, Guiyun Yan, Jetsumon Sattabongkot, Yaming Cao, Bin Chen, Xiaoguang Chen, Qi Fan, Qiang Fang, Somchai Jongwutiwes, Daniel Parker, Jeeraphat Sirichaisinthop, Myat Phone Kyaw, Xin-zhuan Su, Henglin Yang, Zhaoqing Yang, Baomin Wang, Jianwei Xu, Bin Zheng, Daibin Zhong, Guofa Zhou.   

Abstract

The Greater Mekong Subregion (GMS), comprised of six countries including Cambodia, China's Yunnan Province, Lao PDR, Myanmar (Burma), Thailand and Vietnam, is one of the most threatening foci of malaria. Since the initiation of the WHO's Mekong Malaria Program a decade ago, malaria situation in the GMS has greatly improved, reflected in the continuous decline in annual malaria incidence and deaths. However, as many nations are moving towards malaria elimination, the GMS nations still face great challenges. Malaria epidemiology in this region exhibits enormous geographical heterogeneity with Myanmar and Cambodia remaining high-burden countries. Within each country, malaria distribution is also patchy, exemplified by 'border malaria' and 'forest malaria' with high transmission occurring along international borders and in forests or forest fringes, respectively. 'Border malaria' is extremely difficult to monitor, and frequent malaria introductions by migratory human populations constitute a major threat to neighboring, malaria-eliminating countries. Therefore, coordination between neighboring countries is essential for malaria elimination from the entire region. In addition to these operational difficulties, malaria control in the GMS also encounters several technological challenges. Contemporary malaria control measures rely heavily on effective chemotherapy and insecticide control of vector mosquitoes. However, the spread of multidrug resistance and potential emergence of artemisinin resistance in Plasmodium falciparum make resistance management a high priority in the GMS. This situation is further worsened by the circulation of counterfeit and substandard artemisinin-related drugs. In most endemic areas of the GMS, P. falciparum and Plasmodium vivax coexist, and in recent malaria control history, P. vivax has demonstrated remarkable resilience to control measures. Deployment of the only registered drug (primaquine) for the radical cure of vivax malaria is severely undermined due to high prevalence of glucose-6-phosphate dehydrogenase deficiency in target human populations. In the GMS, the dramatically different ecologies, diverse vector systems, and insecticide resistance render traditional mosquito control less efficient. Here we attempt to review the changing malaria epidemiology in the GMS, analyze the vector systems and patterns of malaria transmission, and identify the major challenges the malaria control community faces on its way to malaria elimination. Copyright Â
© 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21382335      PMCID: PMC3132579          DOI: 10.1016/j.actatropica.2011.02.016

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  120 in total

1.  Malaria. Did they really say ... eradication?

Authors:  Leslie Roberts; Martin Enserink
Journal:  Science       Date:  2007-12-07       Impact factor: 47.728

2.  Efficacy of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in northwest Cambodia.

Authors:  Mey Bouth Denis; Reiko Tsuyuoka; Pharath Lim; Niklas Lindegardh; Poravuth Yi; Sophoan Narann Top; Duong Socheat; Thierry Fandeur; Anna Annerberg; Eva Maria Christophel; Pascal Ringwald
Journal:  Trop Med Int Health       Date:  2006-12       Impact factor: 2.622

3.  Mortality rates in conflict zones in Karen, Karenni, and Mon states in eastern Burma.

Authors:  Thomas J Lee; Luke C Mullany; Adam K Richards; Heather K Kuiper; Cynthia Maung; Chris Beyrer
Journal:  Trop Med Int Health       Date:  2006-07       Impact factor: 2.622

4.  Counterfeit and substandard antimalarial drugs in Cambodia.

Authors:  C T Lon; R Tsuyuoka; S Phanouvong; N Nivanna; D Socheat; C Sokhan; N Blum; E M Christophel; A Smine
Journal:  Trans R Soc Trop Med Hyg       Date:  2006-06-12       Impact factor: 2.184

Review 5.  Insecticide resistance in vector mosquitoes in China.

Authors:  Feng Cui; Michel Raymond; Chuan-Ling Qiao
Journal:  Pest Manag Sci       Date:  2006-11       Impact factor: 4.845

6.  Fake artesunate in southeast Asia.

Authors:  P Newton; S Proux; M Green; F Smithuis; J Rozendaal; S Prakongpan; K Chotivanich; M Mayxay; S Looareesuwan; J Farrar; F Nosten; N J White
Journal:  Lancet       Date:  2001-06-16       Impact factor: 79.321

7.  Artemisinin resistance in Plasmodium falciparum malaria.

Authors:  Arjen M Dondorp; François Nosten; Poravuth Yi; Debashish Das; Aung Phae Phyo; Joel Tarning; Khin Maung Lwin; Frederic Ariey; Warunee Hanpithakpong; Sue J Lee; Pascal Ringwald; Kamolrat Silamut; Mallika Imwong; Kesinee Chotivanich; Pharath Lim; Trent Herdman; Sen Sam An; Shunmay Yeung; Pratap Singhasivanon; Nicholas P J Day; Niklas Lindegardh; Duong Socheat; Nicholas J White
Journal:  N Engl J Med       Date:  2009-07-30       Impact factor: 91.245

8.  Cross-border malaria control for internally displaced persons: observational results from a pilot programme in eastern Burma/Myanmar.

Authors:  Adam K Richards; Kristin Banek; Luke C Mullany; Catherine I Lee; Linda Smith; Eh Kalu Shwe Oo; Thomas J Lee
Journal:  Trop Med Int Health       Date:  2009-02-24       Impact factor: 2.622

9.  Spatial and temporal distribution of falciparum malaria in China.

Authors:  Hualiang Lin; Liang Lu; Linwei Tian; Shuisen Zhou; Haixia Wu; Yan Bi; Suzanne C Ho; Qiyong Liu
Journal:  Malar J       Date:  2009-06-12       Impact factor: 2.979

10.  Failure of artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria in southern Cambodia.

Authors:  William O Rogers; Rithy Sem; Thong Tero; Pheaktra Chim; Pharath Lim; Sinuon Muth; Duong Socheat; Frédéric Ariey; Chansuda Wongsrichanalai
Journal:  Malar J       Date:  2009-01-12       Impact factor: 2.979

View more
  141 in total

1.  Natural Plasmodium vivax infections in Anopheles mosquitoes in a malaria endemic area of northeastern Thailand.

Authors:  Petchaboon Poolphol; Ralph E Harbach; Patchara Sriwichai; Kittipat Aupalee; Jetsumon Sattabongkot; Chalermpon Kumpitak; Wichai Srisuka; Kritsana Taai; Sorawat Thongsahuan; Rochana Phuackchantuck; Atiporn Saeung; Udom Chaithong
Journal:  Parasitol Res       Date:  2017-10-29       Impact factor: 2.289

2.  Malaria PCR detection in Cambodian low-transmission settings: dried blood spots versus venous blood samples.

Authors:  Lydie Canier; Nimol Khim; Saorin Kim; Rotha Eam; Chanra Khean; Kaknika Loch; Malen Ken; Pieter Pannus; Philippe Bosman; Jorgen Stassijns; Fabienne Nackers; SweetC Alipon; Meng Chuor Char; Nguon Chea; William Etienne; Martin De Smet; Jean-Marie Kindermans; Didier Ménard
Journal:  Am J Trop Med Hyg       Date:  2015-01-05       Impact factor: 2.345

3.  Genetic diversity of Plasmodium falciparum histidine-rich protein 2 in the China-Myanmar border area.

Authors:  Peipei Li; Hua Xing; Zhenjun Zhao; Zhaoqing Yang; Yaming Cao; Wenli Li; Guiyun Yan; Jetsumon Sattabongkot; Liwang Cui; Qi Fan
Journal:  Acta Trop       Date:  2015-08-20       Impact factor: 3.112

4.  Assessing potential health impacts of waste recovery and reuse business models in Hanoi, Vietnam.

Authors:  Mirko S Winkler; Samuel Fuhrimann; Phuc Pham-Duc; Guéladio Cissé; Jürg Utzinger; Hung Nguyen-Viet
Journal:  Int J Public Health       Date:  2016-08-30       Impact factor: 3.380

5.  Quality Testing of Artemisinin-Based Antimalarial Drugs in Myanmar.

Authors:  Suqin Guo; Myat Phone Kyaw; Lishan He; Myo Min; Xiangxue Ning; Wei Zhang; Baomin Wang; Liwang Cui
Journal:  Am J Trop Med Hyg       Date:  2017-08-18       Impact factor: 2.345

6.  Determinants of MDA impact and designing MDAs towards malaria elimination.

Authors:  Bo Gao; Sompob Saralamba; Yoel Lubell; Lisa J White; Arjen M Dondorp; Ricardo Aguas
Journal:  Elife       Date:  2020-04-15       Impact factor: 8.140

7.  Microgeographically diverse Plasmodium vivax populations at the Thai-Myanmar border.

Authors:  Bhavna Gupta; Daniel M Parker; Qi Fan; B P Niranjan Reddy; Guiyun Yan; Jetsumon Sattabongkot; Liwang Cui
Journal:  Infect Genet Evol       Date:  2016-09-28       Impact factor: 3.342

8.  Clinical Efficacy of Dihydroartemisinin-Piperaquine for the Treatment of Uncomplicated Plasmodium falciparum Malaria at the China-Myanmar Border.

Authors:  Ying Wang; Zhaoqing Yang; Lili Yuan; Guofa Zhou; Daniel Parker; Ming-Chieh Lee; Guiyun Yan; Qi Fan; Yuping Xiao; Yaming Cao; Liwang Cui
Journal:  Am J Trop Med Hyg       Date:  2015-08-17       Impact factor: 2.345

9.  Plasmodium falciparum populations from northeastern Myanmar display high levels of genetic diversity at multiple antigenic loci.

Authors:  Lili Yuan; Hui Zhao; Lanou Wu; Xiaomei Li; Daniel Parker; Shuhui Xu; Yousheng Zhao; Guohua Feng; Ying Wang; Guiyun Yan; Qi Fan; Zhaoqing Yang; Liwang Cui
Journal:  Acta Trop       Date:  2012-09-20       Impact factor: 3.112

10.  Population genetics of the malaria vector Anopheles aconitus in China and Southeast Asia.

Authors:  Bin Chen; Ralph E Harbach; Catherine Walton; Zhengbo He; Daibin Zhong; Guiyun Yan; Roger K Butlin
Journal:  Infect Genet Evol       Date:  2012-09-12       Impact factor: 3.342

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.